Alerts
Other content recommended for you
- Comparison of the therapeutic dose of warfarin in HIV-infected and HIV-uninfected patients: a study of clinical practice
- Gastrointestinal complications of HIV infection: changing priorities in the HAART era
- AIDS and the lung in a changing world
- Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients
- Evaluating the reactivation of herpesviruses and inflammation as cardiovascular and cerebrovascular risk factors in antiretroviral therapy initiators in an African HIV-infected population (RHICCA): a protocol for a longitudinal cohort study
- Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy
- Immunological failure in HIV-infected adults from 2003 to 2015 in Southwest Ethiopia: a retrospective cohort study
- Survival outcomes of primary cutaneous T-cell lymphoma in HIV-infected patients: a national population-based study
- Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy
- Human gammaherpesviruses viraemia in HIV infected patients